Time in the Therapeutic Range for Patients Taking Acenocoumarol at the University Hospital Establishment of Oran in Algeria
Habiba Fetati, Nadjet Fatima Zohra Mekaouche, Fatma Boudia, Asmaa Memou, Saleh Asma, Amara Nihad, Chadou Hacene, Melissa Chabane, Achir Nafisa, Bellil Amina, Bendjilali Hind, Soulimane Rym & Houari Toumi · Journal of Pharmaceutical Research International · 2025
Aims: Acenocoumarol, a vitamin K antagonist anticoagulant, is used in the management of common thromboembolic conditions, such as atrial fibrillation and venous thrombosis. Although it remains a standard treatment in Algeria, its clinical use is hampered by significant interindiv...
Open access
Research Article
10.9734/jpri/2025/v37i127793